Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 3,525 shares at $3.85 ($14K) on 2026-02-10, disclosed to the SEC on 2026-02-11.
Seasonal sale ($14k) by Chief Scientific Officer — this insider has traded VYGR in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |
| VYGR | SELL | 2025-01-15 | $6K | — | Filing → |